Polar Asset Management Partners Inc.
-1.52%
3M Return
$10.190
+0.010 (+0.10%)終値時点
Crown Reserve Acquisition Corp I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focused industries include pharma, medical technology and medical equipment, and healthcare information technology (IT) industries. The Company is not engaged in any business operation and does not have any revenues.
Crown Reserve Acquisition Corp. I (CRAC) is currently trading at $10.19, which is close to its 200-day simple moving average of $10.05. The stock has shown a 1-year change of +2.93%, indicating stability, but the forward P/E ratio is 0, suggesting uncertainty in future earnings. The RSI is at 52.68, indicating a neutral momentum. The main risk is the negative net income reported in Q1 2026 of -263,493 USD, which raises concerns about profitability. Given these factors, it is prudent to hold rather than buy at this time.
Crown Reserve Acquisition Corp I is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focused industries include pharma, medical technology and medical equipment, and healthcare information technology (IT) industries. The Company is not engaged in any business operation and does not have any revenues. It operates in the Financials sector.
Crown Reserve Acquisition Corp. I (CRAC) is currently trading at $10.19, which is close to its 200-day simple moving average of $10.05. The stock has shown a 1-year change of +2.93%, indicating stability, but the forward P/E ratio is 0, suggesting uncertainty in future earnings. The RSI is at 52.68, indicating a neutral momentum. The main risk is the negative net income reported in Q1 2026 of -263,493 USD, which raises concerns about profitability. Given these factors, it is prudent to hold rather than buy at this time.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。